Lv7
5005 积分 2021-05-28 加入
Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial
15小时前
已完结
Prediction of survival after de-escalated neoadjuvant therapy in HER2+ early breast cancer: A pooled analysis of three WSG trials
1个月前
已完结
De-escalated neoadjuvant weekly nab-paclitaxel with trastuzumab and pertuzumab versus docetaxel, carboplatin, trastuzumab, and pertuzumab in patients with HER2-positive early breast cancer (HELEN-006): a multicentre, randomised, phase 3 trial
1个月前
已完结
Efficacy and safety of rituximab induction therapy and effect of rituximab maintenance for IgG4-related disease: a systematic review and meta-analysis
1个月前
已完结
Efficacy and safety of rituximab in patients with lupus nephritis: A systematic review and meta-analysis
1个月前
已完结
High-Dose Rituximab and Early Remission in PLA2R1-Related Membranous Nephropathy
1个月前
已完结
The effectiveness of cultural competence interventions in nursing: A systematic review and meta-analysis
1个月前
已关闭
PI3K/AKT/mTOR inhibitors for hormone receptor-positive advanced breast cancer
1个月前
已完结
Overall Survival and Quality-of-Life Superiority in Modern Phase 3 Oncology Trials
2个月前
已关闭
Premastectomy Radiotherapy and Immediate Breast Reconstruction
2个月前
已完结
皖公网安备34019202002308
